Top

Published in:

28-10-2022 | Systematic Review

Prevalence of hearing loss in patients with Sjögren syndrome: a systematic review and meta-analysis

Authors: Vasileios Paraschou, Styliani Partalidou, Pavlos Siolos, Zoi Papadopoulou, Nikolaos Chaitidis

Published in: Rheumatology International | Issue 2/2023

Abstract

Sjögren syndrome (SS) is a multisystem autoimmune disease, primarily targeting salivary and lacrimal glands; skin, nasal and vaginal dryness, along with musculoskeletal pain and fatigue are the most commonly reported symptoms. Hearing loss is hypothesized to be frequent as well. The purpose of this systematic review was to estimate the prevalence of Hearing loss and its different subtypes in patients with Sjögren syndrome. PRISMA guidelines were followed to ensure highest quality for our systematic review. A random effects model meta-analysis and meta-regression was conducted using I² as heterogeneity indicator. Eleven observational studies were included in this systematic review. Ten of them were cross-sectional, while one study was case–control. Studies were assessed for risk of bias: all were rated to a moderate level, except for two rated to a low level. Pooled prevalence of any type of hearing loss was 52.2%. After excluding studies rated to moderate bias, the pooled prevalence of hearing loss was 36.7%. We also conducted a subgroup analysis depending on type of hearing loss. Pooled prevalence of sensorineural hearing loss was 42.6%., while pooled prevalence of conductive hearing loss and mixed hearing loss were 5% and 2.3%, respectively. Meta-regression was conducted in an effort to identify possible variables capable to explain high heterogeneity between studies. Sample size and year of study were separately found to account for a portion of heterogeneity between studies of sensorineural hearing loss. Year of study was also found to account for a portion of heterogeneity between studies of conductive hearing loss. In conclusion, sensorineural hearing loss, is highly prevalent in patients with Sjögren syndrome. On this basis, early screening and follow-up of patients with Sjögren syndrome by pure tone audiometry is important.

Qin B, Wang J, Yang Z et al (2015) Epidemiology of primary Sjögren’s syndrome: a systematic review and meta-analysis. Ann Rheum Dis 74:1983–1989CrossRef

Mavragani CP, Schini M et al (2012) Brief report: adrenal autoimmunity in primary Sjögren’s syndrome. Arthritis Rheum 64:4066–4071. https://doi.org/10.1002/art.34679CrossRef

Teos LY, Alevizos I (2017) Genetics of Sjögren’s syndrome. Clin Immunol 182:41–47. https://doi.org/10.1016/j.clim.2017.04.018CrossRef

Liu Z, Chu A (2021) Sjögren’s syndrome and viral infections. Rheumatol Ther 8:1051–1059. https://doi.org/10.1007/s40744-021-00334-8CrossRef

Teruel M, Barturen G, Martínez-Bueno M et al (2021) Integrative epigenomics in Sjögren’s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature. Sci Rep 11:23292. https://doi.org/10.1038/s41598-021-01324-0CrossRef

Nocturne G, Mariette X (2013) Advances in understanding the pathogenesis of primary Sjögren’s syndrome. Nat Rev Rheumatol 9:544–556CrossRef

Brito-Zerón P, Baldini C, Bootsma H et al (2016) Sjögren syndrome. Nat Rev Dis Prim 2:1–20. https://doi.org/10.1038/nrdp.2016.47CrossRef

Sebastian A, Szachowicz A, Wiland P (2019) Classification criteria for secondary Sjögren’s syndrome. Current state of knowledge. Reumatologia 57:277–280CrossRef

van Nimwegen JF, van Ginkel MS et al (2018) Validation of the ACR-EULAR criteria for primary Sjögren’s syndrome in a Dutch prospective diagnostic cohort. Rheumatology (Oxford) 57(5):818–825. https://doi.org/10.1093/rheumatology/kex495CrossRef

10.

Gündüz B, Yildirim N, Güven SC et al (2019) Evaluation of medial olivocochlear efferent system and hearing loss in patients with primary Sjögren’s syndrome. Turk J Med Sci 49:1647–1654. https://doi.org/10.3906/sag-1901-128CrossRef

11.

Hatzopoulos S, Amoroso C, Aimoni C et al (2002) Hearing loss evaluation of Sjogren’s syndrome using distortion product otoacoustic emissions. Acta Otolaryngol 122:20–25. https://doi.org/10.1080/00016480260094929CrossRef

12.

Seeliger T, Bönig L, Witte T et al (2020) Hearing dysfunction in patients with Neuro-Sjögren: a cross-sectional study. Ann Transl Med 8:1069CrossRef

13.

Thanooja CV, Augustine AM, Lepcha A et al (2018) Audiological profile in primary Sjögren’s syndrome in a tertiary care setting and its clinical implications. Indian J Otolaryngol Head Neck Surg 70:59–65. https://doi.org/10.1007/s12070-015-0956-yCrossRef

14.

Gk T, Pv V, Pelechas E et al (2019) Cochlear involvement in patients with systemic autoimmune rheumatic diseases: a clinical and laboratory comparative study. Eur Arch Otorhinolaryngol 276:2419–2426CrossRef

15.

Dalton DS, Cruickshanks KJ, Klein BEK et al (2003) The impact of hearing loss on quality of life in older adults. Gerontologist 43:661–668. https://doi.org/10.1093/geront/43.5.661CrossRef

16.

Liu CM, Lee CTC (2019) Association of hearing loss with dementia. JAMA Netw Open 2:e198112. https://doi.org/10.1001/jamanetworkopen.2019.8112CrossRef

17.

Michels TC, Duffy MT, Rogers DJ (2019) Hearing loss in adults: differential diagnosis and treatment. Am Fam Physician 100(2):98–108

18.

Shamseer L, Moher D, Clarke M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. https://doi.org/10.1136/bmj.g7647CrossRef

19.

Sterne JA, Hernán MA, Reeves BC et al (2016) ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ. https://doi.org/10.1136/bmj.i4919CrossRef

20.

Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560CrossRef

21.

Sterne JAC, Sutton AJ, Ioannidis JPA et al (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. https://doi.org/10.1136/bmj.d4002CrossRef

22.

Doig JA, Whaley K, Dick WC et al (1971) Otolaryngological aspects of Sjögren’s syndrome. Br Med J 4:460–463CrossRef

23.

Galarza-Delgado DA, Villegas Gonzalez MJ, Riega Torres J et al (2018) Early hearing loss detection in rheumatoid arthritis and primary Sjögren syndrome using extended high frequency audiometry. Clin Rheumatol 37:367–373. https://doi.org/10.1007/S10067-017-3959-0CrossRef

24.

Gusmão Fernandesa FL, Guimarãesa AC, Scaramussaa LS et al (2014) Otorhinolaryngological findings in a group of patients with rheumatic diseases. Rev Bras Reumatol 54:172–178

25.

Trott MS, Hughes GB, Calabrese LH et al (1996) Hearing and Sjögren’s syndrome. Ear Nose Throat J 75:666–6668CrossRef

26.

Tsirves GK, Voulgari PV, Pelechas E et al (2019) Cochlear involvement in patients with systemic autoimmune rheumatic diseases: a clinical and laboratory comparative study. Eur Arch Otorhinolaryngol 276:2419–2426. https://doi.org/10.1007/s00405-019-05487-5CrossRef

27.

Tumiati B, Casoli P, Parmeggiani A (1997) Hearing loss in the Sjögren syndrome. Ann Intern Med 126:450–453CrossRef

28.

Ziavra N, Politi EN, Kastanioudakis I et al (2000) Hearing loss in Sjögren’s syndrome patients. A comparative study. Clin Exp Rheumatol 18:725–728

29.

Haile LM, Kamenov K, Briant PS et al (2021) Hearing loss prevalence and years lived with disability, 1990–2019: findings from the global burden of disease study 2019. Lancet 397:996–1009. https://doi.org/10.1016/S0140-6736(21)00516-X/ATTACHMENT/A552CF62-9122-4B03-B1AF-AFCE71BE7E9E/MMC1.PDFCrossRef

30.

Goman AM, Lin FR (2016) Prevalence of hearing loss by severity in the United States. Am J Public Health 106:1820–1822. https://doi.org/10.2105/AJPH.2016.303299CrossRef

31.

Emamifar A, Bjoerndal K, Hansen IM (2016) Is hearing impairment associated with rheumatoid arthritis? A review. Open Rheumatol J. https://doi.org/10.2174/1874312901610010026CrossRef

32.

Ahmadzadeh A, Daraei M, Jalessi M et al (2017) Hearing status in patients with rheumatoid arthritis. J Laryngol Otol 131(10):895–899. https://doi.org/10.1017/S0022215117001670CrossRef

33.

Jeong J, Lim H, Lee K et al (2019) High risk of sudden sensorineural hearing loss in several autoimmune diseases according to a population-based national sample cohort study. Audiol Neurotol 24:224–230. https://doi.org/10.1159/000502677CrossRef

34.

Tanaka EA, Barros H, Polanski JF et al (2019) AB0507 hearing loss in systemic lupus erythematosus. Ann Rheum Dis 78:1716–1717. https://doi.org/10.1136/ANNRHEUMDIS-2019-EULAR.5998CrossRef

35.

Abbasi M, Yazdi Z, Kazemifar AM, Bakhsh ZZ (2013) Hearing loss in patients with systemic lupus erythematosus. Glob J Health Sci 5:102–106CrossRef

36.

Talal N, Moutsopoulos HM, Kassan SS (eds) (1987) Sjögren’s syndrome. Springer Berlin Heidelberg, Heidelberg

37.

Fauchais AL, Lambert M, Launay D et al (2004) Antiphospholipid antibodies in primary Sjögren’s syndrome: prevalence and clinical significance in a series of 74 patients. Lupus 13:245–248. https://doi.org/10.1191/0961203304lu1006oaCrossRef

38.

Compadretti GC, Brandolini C, Ignazio T (2005) Sudden sensorineural hearing loss in lupus erythematosus associated with antiphospholipid syndrome: case report and review. Ann Otol Rhinol Laryngol 114:214–218. https://doi.org/10.1177/000348940511400308CrossRef

39.

Teixeira F, Moreira I, Silva AM et al (2013) Neurological involvement in primary Sjögren syndrome. Acta Reumatol Port 38:29–36

40.

Delalande S, de Seze J, Fauchais A-L, Hachulla E et al (2004) Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 83:280–291. https://doi.org/10.1097/01.md.0000141099.53742.16CrossRef

41.

Jourde-Chiche N, Mancini J, Dagher N et al (2012) Antimalarial ototoxicity: an underdiagnosed complication? A study of spontaneous reports to the French pharmacovigilance network. Ann Rheum Dis 71:1586–1587CrossRef

42.

Johansson MSK, Arlinger SD (2003) Prevalence of hearing impairment in a population in Sweden. Int Audiol 42:18–28. https://doi.org/10.3109/14992020309056081CrossRef

43.

Rodríguez-Valiente A, Álvarez-Montero Ó, Górriz-Gil C, García-Berrocal JR (2020) Prevalence of presbycusis in an otologically normal population. Acta Otorrinolaringologica 71:175–180. https://doi.org/10.1016/j.otoeng.2019.05.003CrossRef

44.

Nezos A, Mavragani CP (2015) Contribution of genetic factors to Sjögren’s syndrome and Sjögren’s syndrome related lymphomagenesis. J Immunol Res 2015:754825. https://doi.org/10.1155/2015/754825CrossRef

45.

Psillas G, Binos P, Dimas GG, Daniilidis M, Constantinidis J (2021) Human leukocyte antigen (HLA) influence on prognosis of autoimmune hearing loss. Audiol Res 11:31–37. https://doi.org/10.3390/audiolres11010004CrossRef

46.

Papadimitraki ED, Kyrmizakis DE, Kritikos I, Boumpas DT (2004) Ear-nose-throat manifestations of autoimmune rheumatic diseases. Clin Exp Rheumatol 22:485–494

Title: Prevalence of hearing loss in patients with Sjögren syndrome: a systematic review and meta-analysis
Authors: Vasileios Paraschou
Styliani Partalidou
Pavlos Siolos
Zoi Papadopoulou
Nikolaos Chaitidis
Publication date: 28-10-2022
Publisher: Springer Berlin Heidelberg
Published in: Rheumatology International / Issue 2/2023
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-022-05235-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2023

Impact of cigarette smoking on rheumatoid arthritis-associated lung diseases: a retrospective case control study on clinical and radiological features and prognosis

High-sensitivity cardiac troponin I is a biomarker for increased arterial stiffness in systemic lupus erythematous women with normal kidney function

“Coexistence of IgA nephropathy and renal artery stenosis in Takayasu arteritis: case report and literature review”

Systematic review of associations between concomitant rheumatoid arthritis and peripheral arterial disease, health-related quality of life and functional capacity

Challenges in the diagnosis and management of immune-mediated necrotising myopathy (IMNM) in a patient on long-term statins

Comparison of cutaneous silent period parameters in patients with primary Sjögren’s syndrome with the healthy population and determination of ıts relationship with clinical parameters

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials